In the realm of spasticity management, baclofen takes center stage, offering targeted relief when administered intrathecally. The journey begins with a comprehensive spasticity evaluation, identifying specific muscle groups contributing to stiffness and spasms. A trial, known as the Intrathecal Baclofen Trial, gauges the effectiveness of the intervention, providing crucial insights for decision-making.

During the trial, Baclofen is delivered directly into the spinal fluid through a catheter, allowing continuous monitoring of its impact on spasticity. This trial spans over 48 hours, with evaluations every two hours, providing a comprehensive understanding of the individual’s response. Based on this trial’s success and the overall spasticity assessment, the decision is made on whether or not to proceed with the permanent implantation of an intrathecal baclofen pump.

The pump is a small, programmable device surgically implanted beneath the skin, typically in the abdominal region. Connected to the pump is a thecal catheter, which is inserted into the intrathecal space surrounding the spinal cord. This catheter delivers precise doses of baclofen, directly targeting the neural pathways responsible for heightened muscle tone. The baclofen dosage delivered through a pump is very less when compared to oral baclofen medications as in ITB the baclofen does not need to cross the blood brain barrier.

We lead in spasticity management, utilizing the precision of intrathecal baclofen pumps to unlock relief for our patients. Our expert team, comprising neurologists and rehabilitation professionals, collaborates to craft personalized and innovative solutions.

In the journey of managing spasticity with intrathecal baclofen, we recognize that knowing the details meticulously gives us the chance to treat the patients better. By delving into the intricacies of this precise intervention, we empower individuals to reclaim control over their lives and become more functionally independent.